HCPCS code J9370: Vincristine injection, per 1 mg2026 Medicare rate & RVUs in Oregon
Vincristine sulfate is an intravenous chemotherapy drug reported by oncology providers for each 1 mg administered in a cancer treatment regimen.
CMS doesn’t publish an office rate for J9370 in Oregon.
Medicare allowed amount for participating (non-QP) physicians, before deductible, coinsurance and claim adjustments. Not a patient’s bill or a hospital charge.
Your location
On this page 9 sections
What J9370 covers
Vincristine sulfate is an antineoplastic medicine given intravenously, commonly as part of combination chemotherapy for cancers such as leukemia, lymphoma, neuroblastoma, and Wilms tumor. Oncology practices and hospital departments report the drug when it is furnished for a patient’s treatment; the administration method may be an IV push or infusion, depending on the regimen. The code identifies vincristine itself, not the service of administering it.
Medicare assigns this drug status E, meaning it is excluded from the physician fee schedule by regulation. When Medicare covers the drug, payment is made under another payment method; the HCPCS pricing method identifies it as a Part B drug generally priced from CMS’s quarterly ASP files. Special Medicare coverage instructions apply. Each code unit represents 1 mg of vincristine sulfate, so report units based on the dose furnished.
This summary was written with AI assistance from CMS physician fee schedule data and checked against the CMS billing rules shown here. Rates on this page come directly from CMS files.
Where J9370 pays more and less in Oregon
| Payment locality | Office | Facility |
|---|---|---|
| Portland, OR | Unavailable | Unavailable |
| Rest of Oregon | Unavailable | Unavailable |
How the J9370 rate is calculated
Each of J9370’s three RVUs is multiplied by a geographic index (GPCI) for the payment locality, added up, and multiplied by the conversion factor. Drag the indexes or enter a ZIP to see what moves the rate.
How the rate is built · J9370
RVUs × geographic indexes × conversion factor
Work0.00
0.00 RVUs× 1.000 GPCI
Practice expense0.00
0.00 RVUs× 1.000 GPCI
Malpractice0.00
0.00 RVUs× 1.000 GPCI
Adjusted RVUs
0.0000
Conversion factor
$33.4009
Medicare rate
$0.00
Every GPCI starts at 1.000, the national rate. Enter a ZIP or drag a slider.
Payment rules and modifiers for J9370
J9370 has no global surgery period, no multiple-procedure, bilateral or assistant-at-surgery adjustment, and no professional/technical split. What changes the payment is where the service happens: the place of service on the claim decides whether Medicare pays the office or the facility rate.
Place of service · J9370
Which rate does Medicare pay?
The POS code on the claim line (CMS-1500 box 24B).
POS 11 · non-facility rate · national
—
J9370 isn’t priced in this setting.
J9370 compared with similar codes
Compare codes · National
4 codes, side by side
How to choose
- J9360Vinblastine injectionPer 1 mg
- J9360 identifies vinblastine sulfate, a different vinca alkaloid. Use J9370 for vincristine sulfate.
- J9390Vinorelbine injectionPer 10 mg
- J9390 identifies vinorelbine tartrate. It is a different chemotherapy drug from vincristine sulfate.
- J9351Topotecan injectionPer 0.1 mg
- J9351 identifies topotecan, not vincristine. Choose according to the drug administered.
J9370 billing questions
How many units represent a 2 mg dose?
Each unit represents 1 mg, so a 2 mg dose corresponds to 2 units.
Is this the same drug as vinblastine?
No. J9370 identifies vincristine sulfate; J9360 identifies vinblastine sulfate. Select the code for the drug actually furnished.
Does J9370 include chemotherapy administration?
No. J9370 identifies the drug. Report a separately reportable chemotherapy administration service using the code that matches how it was administered.
How does Medicare treat this code?
It has physician fee schedule status E and is excluded from that schedule by regulation. When Medicare covers the drug, payment is under another method; the HCPCS pricing method identifies it as a Part B drug generally priced from quarterly ASP files.
What should the claim documentation support?
Document the vincristine sulfate furnished, the administered dose, and the route. The reported units should reflect the dose in 1 mg increments.
Where these rates come from
FeeBase calculates base physician payments from CMS work, practice-expense and malpractice RVUs, adjusted by each locality’s geographic indexes and the conversion factor. Services without a published rate are labeled, never given a made-up amount. Amounts are Medicare allowed amounts before claim adjustments: not a patient’s bill or a commercial rate.
CMS RVU26D · effective Oct 1, 2026 through the day before Jan 1, 2027
Fee sheets · Coming soon
Put J9370 and the rest of your codes on one sheet
Your codes at your locality, with payer contracts beside Medicare.
Join the waitlist